Pub. Date : 1998 Aug 28
PMID : 9748607
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages. | Arachidonic Acid | interleukin 13 | Mus musculus |
| 2 | Pretreatment of mouse peritoneal macrophages with interleukin-13 (IL-13) potentiates the mobilization of arachidonic acid (AA) and the production of HETEs but does not affect the production of cyclooxygenase metabolites triggered by the suboptimal concentration of an inflammatory agonist (opsonized-zymosan). | Arachidonic Acid | interleukin 13 | Mus musculus |
| 3 | Pretreatment of mouse peritoneal macrophages with interleukin-13 (IL-13) potentiates the mobilization of arachidonic acid (AA) and the production of HETEs but does not affect the production of cyclooxygenase metabolites triggered by the suboptimal concentration of an inflammatory agonist (opsonized-zymosan). | Arachidonic Acid | interleukin 13 | Mus musculus |
| 4 | Pretreatment of mouse peritoneal macrophages with interleukin-13 (IL-13) potentiates the mobilization of arachidonic acid (AA) and the production of HETEs but does not affect the production of cyclooxygenase metabolites triggered by the suboptimal concentration of an inflammatory agonist (opsonized-zymosan). | Zymosan | interleukin 13 | Mus musculus |
| 5 | Pretreatment of mouse peritoneal macrophages with interleukin-13 (IL-13) potentiates the mobilization of arachidonic acid (AA) and the production of HETEs but does not affect the production of cyclooxygenase metabolites triggered by the suboptimal concentration of an inflammatory agonist (opsonized-zymosan). | Zymosan | interleukin 13 | Mus musculus |
| 6 | Cycloheximide suppresses these effects of IL-13 suggesting that de novo protein synthesis is involved. | Cycloheximide | interleukin 13 | Mus musculus |